New pill could cut blood transfusions for blood disorders
Disease control
Completed
This study tested an experimental drug called etavopivat in 53 people with sickle cell disease or thalassemia. The goal was to see if the drug could safely reduce the need for red blood cell transfusions and increase hemoglobin levels. Participants took the drug by mouth, and res…
Phase: PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC